IO Biotech, Inc.
IOBTDelisted Jun 8, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001865494
IO Biotech, Inc. was delisted on Jun 8, 2026; its insiders filed their last Form 4 on Jun 6, 2025; 12 institutions reported holding it in 13F filings for Q1 2026, worth $199.0K in total; no superinvestor held it.
Q4 2025 vs. Q3 2025
How the institutions holding IO Biotech, Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 21 | 22 | +1 |
| Shares | 9.90M | 7.85M | −2.05M (−20.7%) |
| Value | $3.59M | $4.78M | +$1.19M (+33.1%) |
New holders (5)
Institutions that held IO Biotech, Inc. at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Beacon Pointe Advisors, LLC | 506,000 | $308.1K | 0.00% |
| Dauntless Investment Group, LLC | 451,641 | $275.0K | 1.01% |
| Two Sigma Securities, LLC | 44,757 | $27.3K | 0.00% |
| ADAR1 Capital Management, LLC | 24,964 | $15.2K | 0.00% |
| Scientech Research LLC | 11,255 | $6.85K | 0.00% |
Sold out (4)
Institutions that held IO Biotech, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Point72 Asset Management, L.P. | 250,000 | $90.8K |
| Quadrature Capital Ltd | 83,382 | $30.3K |
| Goldman Sachs Group Inc | 66,564 | $24.2K |
| GWM Advisors LLC | 25,692 | $9.33K |